Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTO-207 in Treatment-resistant Depression
NCT07553637Phase 2Recruiting
- Sponsor
- Alto Neuroscience
- Start
- May 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial, sponsored by Alto Neuroscience. Started May 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07553637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553637.